Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: Role of F18-FDG PET

Biomedicine and Pharmacotherapy

Volumn 58, Issue 8 SPEC. ISS., 2004, Pages 451-457

  Capirci, Carlo ^a   Rubello, Domenico ^b   Chierichetti, Franca ^c   Crepaldi, Giorgio ^a   Carpi, Angelo ^d   Nicolini, Andrea ^d   Mandoliti, Giovanni ^a   Polico, Cesare ^a  

^a ASL 18   (Italy)

^b S Maria Della Misericordia R

^c Castelfranco Veneto Hospital   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Rectal cancer

Indexed keywords

BARIUM; FLUORODEOXYGLUCOSE F 18;

ABDOMEN; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LIVER; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RECTOSCOPY; RECTUM BIOPSY; RECTUM CARCINOMA; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TUMOR REGRESSION;

EID: 5344244696     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2004.08.005     Document Type: Article

References (71)

1. Stockholm Rectal Cancer Study Group Preoperative short term radiotherapy in operable rectal carcinoma: a prospective randomized trial Cancer 66 1990 49 55
2. L. Pahlman, and B. Glimelius Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma Ann. Surg. 211 1990 187 195
3. Swedish Rectal Cancer Trial Improved survival with preoperative radiotherapy in respectable rectal cancer NEIM 336 1997 980 987
4. Medical Research Council Rectal Cancer Working Party Randomized trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer Lancet 348 1996 1605 1610
5. W.E. MacMillan, W.H. Wolberg, and P. Welling Pharmacokinetics of 5-fluorouracil in humans Cancer Res. 38 1978 3479 3482
6. J. Spratt, and J. Spratt Growth rates of benign and malignant neoplasm of the colon J. Ingall A. Mastromarino Carcinoma of the large bowel and its precursors 1985 Alan K. Liss New York 103 120
7. J.A. Koutcher, A.A. Alfieri, and H. Thaler Radiation enhancement by biochemical modulation and 5-fluoro-uracil Int. J. Radiat. Oncol. Biol. Phys. 39 1997 1145 1152
8. T.S. Lawrence, J.E. Tepper, and A.W. Blackshock Fluoropyrimidine- radiation interactions in cell and tumours Sermin. Radiat. Oncol. 7 1997 260 266
9. T.A. Rich Irradiation plus 5-fluoro-uracil: Cellular mechanisms of action and treatment schedules Sem. Radiat. Oncol. 7 1997 267 273
10. C.G. Willet The role of radiation therapy and 5-fluorouracil in colon and rectal cancer Semin. Radiat. Oncol. 7 1997 300 305
11. A. Grann, B.D. Minsky, and A.M. Cohen Preliminary results of pre-operative 5-fluorouracil (5-FU), low dose leucovorin, and concurrent radiation therapy for respectable T3 rectal cancer Dis. Colon Rectum 40 1999 515 522
12. B.D. Minsky, A.M. Cohen, and W.E. Enker Preoperative 5-FU low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer Int. J. Radiat. Oncol. Biol. Phys. 37 1997 289 295
13. N.A. Janjan, C.N. Crane, and B.W. Feig Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer Int. J. Radiat. Oncol. Biol. Phys. 47 2000 713 718
14. N.A. Janjan, V.S. Khoo, and J. Abruzzese Tumor down staging and sphincter preservation with pre-operative chemoradiation in locally advanced rectal cancer: the M.D. Anderson Cancer Center Experience Int. J. Radiat. Oncol. Biol. Phys. 44 1999 1027 1038
15. V. Valentini, C. Coco, and N. Cellini Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation Int. J. Radiat. Oncol. Biol. Phys. 40 1998 1067 1075
16. G.A. Fortier, W.C. Constable, and H. Meyers Preoperative radiation therapy for rectal cancer Arch. Surg. 121 1986 1380 1384
17. R. Wong, G. Thomas, and B. Cummings In search of a dose-response relationship with radiotherapy in the management of recurrent rectal carcinoma in the pelvis: A systematic review Int. J. Radiat. Oncol. Biol. Phys. 40 1998 437 446
18. M. Mohiuddin, W.F. Regine, W. John, and P.F. Hagihara Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathologic complete response Int. J. Radiat. Oncol. Biol. Phys. 42 2000 883 888
19. M. Overgaard, J. Overgaard, and A. Sell Dose-response relationship for radiation therapy of recurrent, residual, and primarily inoperable rectal cancer Radiother. Oncol. 1 1984 217 225
20. M. Mohiuddin, G.J. Marks, and J. Bannon High dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancer Int. J. Radiat. Oncol. Biol. Phys. 30 1994 845 849
21. V. Valentini, C. Coco, and A.G. Morganti Preoperative chemoradiation in extraperitoneal T3-T4 rectal carcinoma: a 10-year experience Osp. Ital. Chir. 6 2000 630 635
22. M.C. Kaminsky-Forret, T. Conroy, and E. Luporosi Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer Int. J. Radiat. Oncol. Biol. Phys. 5 1998 935 941
23. N.R. Ahmad, D.A. Nagle, and A. Topham Pathologic complete response predicts long-term survival following preoperative radiation therapy for rectal cancer Int. J. Radiat. Oncol. Biol. Phys. 39 suppl 1997 284
24. C. Berger, A. De Muret, and P. Garaud Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor down staging and residual tumor cell density (RTCD): prognostic implications Int. J. Radiat. Oncol. Biol. Phys. 37 1997 619 627
25. G. Marks, M. Mohiuddin, and L. Masono High-dose preoperative radiation therapy as the key to extending sphincter preservation surgery for cancer of the distal rectum Surg. Oncol. Clin. N. Am. 1 1 1992 71 86
26. R.D. Marsh, N.M. Chu, and J.N. Vauthey Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaper 5-fluorouracil infusion and radiation therapy Cancer 78 1996 217 225
27. G.M. Videtic, B.J. Fisher, and F.E. Perera Preoperative radiation with concurrent 5-fluoro-uracil continuous infusion for locally advanced unresectable rectal cancer Int. J. Radiat. Oncol. Biol. Phys. 42 1998 319 324
28. T.A. Rich, J.M. Skibber, and J.A. Ajani Preoperative infusional chemoradiation therapy for stage T3 rectal cancer Int. J. Radiat. Oncol. Biol. Phys. 32 1998 1025 1029
29. E.T. Chen, M. Mohiuddin, and H. Brodovsky Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation Int. J. Radiat. Oncol. Biol. Phys. 30 1994 169 175
30. B. Movsas, A.L. Hanlon, and R. Lanciano Phase I dose escalating trial of hyperfractionated preoperative chemoradiation for locally advanced rectal cancer Int. J. Radiat. Oncol. Biol. Phys. 42 1998 43 50
31. A. Habr-Gama, P.M. De Souza, and U. Ribeiro Jr. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment Dis. Colon Rectum 41 1998 1087 1096
32. T.H.A. Arulampalam, D.C. Costa, and M. Loizidou Positron emission tomography and colorectal cancer Br. J. Surg. 88 2001 176 179
33. H. Kwork, I.P. Bisset, and G.L. Hill Preoperative staging of rectal cancer Int. J. Colorectal Dis. 15 2000 9 20
34. A. Bernini, K.I. Deen, and R.D. Madoff Preoperative adjuvant radiation with chemotherapy for rectal cancer: its impact on stage and the role of endorectal ultrasound Ann. Surg. Oncol. 3 1996 131 135
35. S.P. Hiotis, S.M. Weber, and A.M. Cohen Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients J. Am. Coll. Surg. 194 2 2002 131 135
36. B. Napoleon, B. Pujol, and F. Berger Accuracy of endosonography in the staging of rectal cancer treated by radiotherapy Br. J. Surg. 78 1991 785 788
37. J.W. Fleshman, R.J. Myerson, and R. Fryer Accuracy of ultrasound in predicting pathologic stage of rectal cancer before and after preoperative radiation therapy Dis. Colon Rectum 35 1992 823 829
38. B. Rau, M. Hunerbein, and C. Barth Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer Surg. Endosc. 13 1999 980 984
39. B. Barbaro, A. Schulsinger, and V. Valentini The accuracy of transrectal ultrasound in predicting the pathological stage of low-lying rectal cancer after preoperative chemoradiation therapy Int. J. Radiat. Oncol. Biol. Phys. 43 1999 1043 1047
40. F. Glaser, C. Kunz, and P. Schiag Endorectal ultrasound for control of preoperative radiotherapy of rectal cancer Ann. Surg. 217 1993 64 71
41. M. Gavioli, A. Bagni, and I. Piccagli Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer: comparison between sonographic and histopatologic changes Dis. Colon Rectum 43 2000 1075 1083
42. Y. Yonecura, R.S. Benua, and A.B. Brill Increased accumulation of 2-deoxy-2-[18F]fluoro-D-glucose in liver metastases from colon carcinoma J. Nucl. Med. 23 1982 1133 1137
43. P. Som, H.L. Atkins, and D. Bandoypadhyay A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose: nontoxic tracer for rapid tumor detection J. Nucl. Med. 21 1980 670 675
44. H. Abdel-Nabi, R.J. Doerr, and D.M. Lamonica Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings Radiology 206 1998 755 760
45. M. Shelling, N. Avril, and J. Nahring Positron emission tomography using [18F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer J. Clin. Oncol. 18 2000 1689 1695
46. B. Brucher, W. Weber, and M. Bauer Neoadjuvant therapy of esofageal squamous cell carcinoma: response evaluation by positron emission tomography Ann. Surg. 233 2001 300 309
47. A. Eishbruch, Y. Nakamoto, and E.D. Achtyes Early post-therapy prediction of cervix cancer recurrence using positron emission tomography (PET) ASCO Proceedings 2001 2471
48. W.A. Weber, K. Ott, K. Becker, and H.J. Dittler Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging J. Clin. Oncol. 19 12 2001 3058 3065
49. M.R. Roman, M.A. Rossleigh, and S. Angelides Staging and managing lung tumors using F-18 FDG coincidence detection Clin. Nucl. Med. 26 5 2001 383 388
50. M.P. Stokkel, A. Draisma, and E.K. Pauwels Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma J. Cancer Res. Clin. Oncol. 127 5 2001 278 285
51. M. De Wit, K.H. Bohuslavizki, and R. Buchert 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma Ann. Oncol. 12 1 2001 29 37
52. M. Kunkel The role of FDG-PET in the management of oral squamous cell carcinoma H. Wieler R. Colemann PET in Clinical Oncology 2000 Steinkopf Darmstadtp 139 153 vol. 1
53. H. Vesselle, R.A. Schmidt, and J.M. Pugsley Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography Clin. Cancer Res. 6 10 2000 3837 3844
54. C. Schiepers, K. Haustermans, and K. Geboes The effect of preoperative radiation therapy on glucose utilization and cell kinetics in patients with primary rectal carcinoma Cancer 85 1999 803 811
55. E. Bombardieri, G. Aliberti, and C. De Graaf Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer Semin. Surg. Oncol. 20 2 2001 134 146
56. T.H.A. Arulampalam, D.C. Costa, and M. Loizidou Positron emission tomography and colorectal cancer Br. J. Surg. 88 2001 176 189
57. J.C. Guillerm, J. Puig La Calle, and T. Akhurst Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-Fluorodeoxyglucose Positron Emission Tomography Dis. Colon Rectum 43 2000 18 24
58. G.U. Hung, Y.C. Shiau, and S.C. Tsai Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer Anticancer Res. 21 2B 2001 1375 1378
59. F. Stelzner, and J. Ruhlmann PET studies of recurrent rectal carcinoma. Fundamental aspects of lymphatic metastasis of visceral and somatic carcinomas Chirurg. 72 5 2001 537 546
60. E.E. Zervos, D.C. Desai, and L.R. DePalatis 18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study J. Surg. Res. 97 1 2001 9 13
61. K.C. Park, J. Schwimmer, and J.E. Shepherd Decision analysis for the cost-effective management of recurrent colorectal cancer Ann. Surg. 233 3 2001 310 319
62. C. Capirci, C. Stevanin, and G. Mandoliti Small bowel exclusion during pelvic RT by "dynamic" planning al universal simulator: advantages vs "static" CT-scan plan Radiother. Oncol. 32 1994 162 (abstr)
63. Capirci C., Polico C., Mandoliti G. Dislocation of small bowel volume within box pelvic treatment fields, using the new "Up Down Table" device. Int. J. Radiat. Oncol. Biol. Phys.
64. A.B. Miller Reporting result of cancer treatment Cancer 47 1981 207 214
65. P. Quirke, P. Durdey, and M.F. Dixon Local recurrence of rectal adenocarcinoma due to inadeguate surgical resection. Histopathological study of lateral tumour spread and surgical excision Lancet 2 1986 996 999
66. P. Quirke, and M.F. Dixon The prediction of local recurrence in rectal adenocarcinoma by histopathological examination Int. J. Colorectal Dis. 3 1988 127 131
67. A.M. Mandard, F. Dalibard, and J.C. Mandard Pathologic assessment of tumor regression after preoperative CRT of esophageal carcinoma. Clinicopathologic correlations Cancer 73 11 1994 2680 2686
68. S. Pucciarelli, M.L. Friso, and P. Toppan Preoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: preliminary results Ann. Surg. Oncol. 7 2000 38 44
69. C.G. Willet, G. Warland, and M.P. Hagan Tumor proliferation in rectal cancer following preoperative irradiation J. Clin. Oncol. 13 1995 1417 1424
70. V. Valentini, C. Coco, and A. Picciocchi Does down staging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int. J. Radiat. Oncol. Biol. Phys. 53 2002 664 674
71. I.J. Haberkorn, L.G. Strauas, and A. Dimitracopoulou PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumours receiving radiotherapy J. Nucl. Med. 32 1991 1485 1490